Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial

Pediatrics

Volumn 116, Issue 5, 2005, Pages

  Van Wassenaer, Aleid G ^a   Westera, Jolanda ^a   Houtzager, Bregje A ^a   Kok, Joke H ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Controlled trial; Premature infants; Psychomotor development; Randomized; School performance; Thyroid function

Indexed keywords

THYROXINE;

ACADEMIC ACHIEVEMENT; ARTICLE; CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; MALE; MOTOR PERFORMANCE; NEWBORN; PARENTAL STRESS; PREMATURITY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME; BLOOD; BRAIN; DEVELOPMENTAL DISORDER; EDUCATION; GROWTH, DEVELOPMENT AND AGING; INFANT; INTELLIGENCE; PHYSIOLOGY; PRESCHOOL CHILD; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE;

BRAIN; CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; DOUBLE-BLIND METHOD; EDUCATION, SPECIAL; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INTELLIGENCE; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; THYROXINE;

EID: 33644664273     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-0876     Document Type: Article

References (25)

1. Bernal J, Nunez J. Thyroid hormones and brain development. Eur J Endocrinol. 1995;133:390-398
2. Rooman RP, Du Caju MV, De Beeck LO, Docx M, Van Reempts P, Van Acker KJ. Low thyroxinaemia occurs in the majority of very preterm newborns. Eur J Pediatr. 1996;155:211-215
3. van Wassenaer AG, Kok JH, Dekker FW, de Vijlder JJ. Thyroid function in very preterm infants: influences of gestational age and disease. Pediatr Res. 1997;42:604-609
4. Biswas S, Buffery J, Enoch H, Bland JM, Walters D, Markiewicz M. A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome. Pediatrics. 2002;109:222-227
5. Williams FLR, Simpson J, Delahunty C, et al. Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab. 2004;89:5314-5320
6. Santini F, Chiovato L, Ghirri P, et al. Serum iodothyronines in the human fetus and the newborn: evidence for an important role of placenta in fetal thyroid hormone homeostasis. J Clin Endocrinol Metab. 1999;84:493-498
7. Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med. 1996;334:821-827
8. Lucas A, Morley R, Fewtrell MS. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ. 1996;312:1132-1133; discussion 1133-1134
9. Van Wassenaer AG, Briët JM, Van Baar AL, et al. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants. Pediatrics. 2002;109:534-539
10. Perlman JM. Neurobehavioral deficits in premature graduates of intensive care - potential medical and neonatal environmental risk factors. Pediatrics. 2001;108:1339-1348
11. van Wassenaer AG, Kok JH, de Vijlder JJM, et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med. 1997;336:21-26
12. Briet JM, Van Wassenaer AG, Dekker FW, De Vijlder JJM, Van Baar AL, Kok JH. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics. 2001;107:712-718
13. Hendersen SE, Sugden DA. Movement Assessment Battery for Children-Checklist. Lisse, Netherlands: Swets and Zeitlinger; 1998
14. Verhulst FC, Van den Ende J, Koot HM. Manual for the CBCL 4-18 [in Dutch]. Rotterdam, Netherlands: Department of Child en Adolescent Psychiatry, Sophia Children's Hospital/Academic Hospital Rotterdam/Erasmus University; 1997
15. Verrips EGH, Vogels TGC, Koopman HM, et al. Measuring health-related quality of life in a child population. Eur J Public Health. 1999;9:188-193
16. Abidin RR, De Brock AJLL, Gerrits JRM, Vermulst AA. NOSI: Nijmeegse Ouderlijke Stress Index. Lisse, Netherlands: Swets and Zeitlinger; 1992
17. Hille ET, den Ouden AL, Bauer L, van den Oudenrijn C, Brand R, Verloove-Vanhorick SP. School performance at nine years of age in very premature and very low birth weight infants: perinatal risk factors and predictors at five years of age. Collaborative Project on Preterm and Small for Gestational Age (POPS) Infants in the Netherlands. J Pediatr. 1994;125:426-434
18. Smith LM, Leake RD, Berman N, Villanueva S, Brasel JA. Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity. J Perinatol. 2000;20:427-431
19. Vanhole C, Aerssens P, Naulaers G, et al. L-thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatr Res. 1997;42:87-92
20. Biswas S, Buffery J, Enoch H, Bland M, Markiewicz M, Walters D. Pulmonary effects of triiodothyronine and hydrocortisone supplementation in preterm infants less than 30 weeks gestation: results of the THORN Trial-Thyroid Hormone Replacement in Neonates. Pediatr Res. 2003;53:48-56
21. Schussler GC. Thyroxine-binding proteins [published correction appears in Thyroid. 1991;1:201]. Thyroid. 1990;1:25-34
22. Van Wassenaer AG, Kok JH. Hypothyroxinemia and thyroid function after preterm birth. Semin Neonatol. 2004;9:3-11
23. Cao XY, Jiang XM, Dou ZH, et al. Timing of vulnerability of the brain into iodine deficiency in endemic cretinism. N Engl J Med. 1994;331:1739-1744
24. Levinton A, Paneth N, Reuss ML, et al: Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr. 1999;134:706-711
25. Van der Meulen BF, Smrkovsky M. De Bayley Ontwikkelingsschalen (BOS 2-30). Lisse, Netherlands: Swets and Zeitlinger; 1983